Brookline Capital Markets Reiterates SQZ Biotechnologies (SQZ) at Buy with $42 PT, Grant Announcement is Very Supportive of SQZ's Potential

Go back to Brookline Capital Markets Reiterates SQZ Biotechnologies (SQZ) at Buy with $42 PT, Grant Announcement is Very Supportive of SQZ's Potential
(NYSE: SQZ) Delayed: 0.44 --0 (-0%)
Previous Close $0.44    52 Week High
Open $2.47    52 Week Low
Day High $0.44    P/E N/A 
Day Low $0.44    EPS
Volume 6,038,583